{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T19:28:29Z","timestamp":1772220509474,"version":"3.50.1"},"reference-count":58,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T00:00:00Z","timestamp":1732147200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100015239","name":"Society for Pediatric Pathology","doi-asserted-by":"publisher","award":["SPP Young Investigator Research Grant"],"award-info":[{"award-number":["SPP Young Investigator Research Grant"]}],"id":[{"id":"10.13039\/100015239","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>The most common pediatric primary malignant bone tumor, osteosarcoma, is often described as genetically non-recurrent and heterogeneous. Neoadjuvant chemotherapy is typically followed by resection and assessment of treatment response, which helps inform prognosis. Identifying biomarkers that may impact chemotherapy response and survival could aid in upfront risk stratification and identify patients in highest need of innovative therapies for future clinical trials. Relative to conventional genetics, little is known about osteosarcoma epigenetics. We aimed to characterize the methylation and phosphorylation status in osteosarcoma using histone markers found in primary diagnostic biopsies and their paired metastases. We constructed two tissue microarray sets from 58 primary diagnostic samples and 54 temporally-separated but related metastatic or recurrent samples, with tissue blocks available from 2002\u20132022. Clinical charts were reviewed for post-therapy necrosis response, presence of metastatic disease or recurrence, and overall survival. We evaluated 6 histone H3 residues using immunohistochemistry, including H3K4me3, H3K9me3, H3K27me2, H3K27me3, H3S10T11phos, and H3S28phos. Tumors were scored with low (&lt;25%) or high (\u226525%) nuclear staining of tumor cells. Diagnostic biopsies with low H3K27me3 nuclear staining were associated with poor treatment response (\u226490% necrosis) at the time of definitive excision (P&lt;0.05). We observed loss of H3S10T11phos expression in metastatic and recurrent resections specimens compared to the primary tumor (P&lt;0.05). Expression patterns for the remaining histone markers did not show significant associations with disease parameters or survival. Although larger cohort studies are needed, these results support the expanded evaluation of histone markers, particularly H3K27me3 and H3S10T11phos, in osteosarcoma biology and risk stratification.<\/jats:p>","DOI":"10.1371\/journal.pone.0309471","type":"journal-article","created":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T13:40:43Z","timestamp":1732196443000},"page":"e0309471","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":3,"title":["Immunohistochemical study of histone protein 3 modification in pediatric osteosarcoma identifies reduced H3K27me3 as a marker of poor treatment response"],"prefix":"10.1371","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-0339-5714","authenticated-orcid":true,"given":"Sebastian","family":"Kondratowski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danielle","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca J.","family":"Deyell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5194-7892","authenticated-orcid":true,"given":"Ash","family":"Sandhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9432-2390","authenticated-orcid":true,"given":"Jonathan W.","family":"Bush","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2024,11,21]]},"reference":[{"issue":"7","key":"pone.0309471.ref001","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1002\/cncr.24121","article-title":"Osteosarcoma incidence and survival rates from 1973 to 2004: data from the Surveillance, Epidemiology, and End Results Program","volume":"115","author":"L Mirabello","year":"2009","journal-title":"Cancer"},{"key":"pone.0309471.ref002","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ejca.2018.11.027","article-title":"Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort","volume":"109","author":"S Smeland","year":"2019","journal-title":"Eur J Cancer"},{"issue":"1","key":"pone.0309471.ref003","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/ijc.24320","article-title":"International osteosarcoma incidence patterns in children and adolescents, middle ages and elderly persons","volume":"125","author":"L Mirabello","year":"2009","journal-title":"Int J Cancer"},{"issue":"3","key":"pone.0309471.ref004","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1200\/JCO.2002.20.3.776","article-title":"Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols","volume":"20","author":"SS Bielack","year":"2002","journal-title":"J Clin Oncol"},{"issue":"10","key":"pone.0309471.ref005","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1200\/JCO.2003.08.132","article-title":"Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols","volume":"21","author":"L Kager","year":"2003","journal-title":"J Clin Oncol"},{"issue":"7","key":"pone.0309471.ref006","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1200\/JCO.2005.03.5352","article-title":"Results of the Brazilian Osteosarcoma Treatment Group Studies III and IV: prognostic factors and impact on survival","volume":"24","author":"AS Petrilli","year":"2006","journal-title":"J Clin Oncol"},{"key":"pone.0309471.ref007","unstructured":"Amrita B, Hogendoorn PCW, Baumhoer D. Osteosarcoma in: WHO Classification of Tumors [Internet; beta version ahead of print]. Lyon (France): International Agency for Research on Cancer; 2022 [Cited: 2023 May 10]. (WHO Classification of tumours series, 5th ed.; vol 7). https:\/\/tumourclassification.iarc.who.int\/chapters\/44."},{"issue":"3","key":"pone.0309471.ref008","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/s41588-019-0576-7","article-title":"Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing","volume":"52","author":"I Cort\u00e9s-Ciriano","year":"2020","journal-title":"Nat Genet"},{"issue":"5","key":"pone.0309471.ref009","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1200\/JCO.1994.12.5.925","article-title":"Germline mutations of the p53 tumor suppressor gene in children with osteosarcoma","volume":"12","author":"JF McIntyre","year":"1994","journal-title":"J Clin Oncol"},{"issue":"1","key":"pone.0309471.ref010","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.celrep.2014.03.003","article-title":"Recurrent somatic structural variations contribute to tumorigenesis in pediatric osteosarcoma","volume":"7","author":"X Chen","year":"2014","journal-title":"Cell Rep"},{"issue":"51","key":"pone.0309471.ref011","doi-asserted-by":"crossref","first-page":"E5564","DOI":"10.1073\/pnas.1419260111","article-title":"Complementary genomic approaches highlight the PI3K\/mTOR pathway as a common vulnerability in osteosarcoma","volume":"111","author":"JA Perry","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"pone.0309471.ref012","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1001\/jamaoncol.2020.0197","article-title":"Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in Patients With Osteosarcoma","volume":"6","author":"L Mirabello","year":"2020","journal-title":"JAMA Oncol"},{"issue":"1","key":"pone.0309471.ref013","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/s41572-022-00409-y","article-title":"Osteosarcoma","volume":"8","author":"HC Beird","year":"2022","journal-title":"Nat Rev Dis Primers"},{"issue":"4","key":"pone.0309471.ref014","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.cell.2007.02.005","article-title":"Chromatin modifications and their function","volume":"128","author":"T. Kouzarides","year":"2007","journal-title":"Cell"},{"issue":"6","key":"pone.0309471.ref015","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1158\/1078-0432.CCR-08-2091","article-title":"Genomic analysis using high-density single nucleotide polymorphism-based oligonucleotide arrays and multiplex ligation-dependent probe amplification provides a comprehensive analysis of INI1\/SMARCB1 in malignant rhabdoid tumors","volume":"15","author":"EM Jackson","year":"2009","journal-title":"Clin Cancer Res"},{"issue":"9","key":"pone.0309471.ref016","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.3390\/cancers12092710","article-title":"Landscape of Genome-Wide DNA Methylation of Colorectal Cancer Metastasis","volume":"12","author":"C Ili","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"5","key":"pone.0309471.ref017","doi-asserted-by":"crossref","first-page":"e20191340","DOI":"10.1084\/jem.20191340","article-title":"Glioma stem-like cells evade interferon suppression through MBD3\/NuRD complex-mediated STAT1 downregulation","volume":"217","author":"X Zhan","year":"2020","journal-title":"J Exp Med"},{"issue":"6","key":"pone.0309471.ref018","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/modpathol.2016.45","article-title":"Loss of H3K27 tri-methylation is a diagnostic marker for malignant peripheral nerve sheath tumors and an indicator for an inferior survival","volume":"29","author":"AH Cleven","year":"2016","journal-title":"Mod Pathol"},{"issue":"10","key":"pone.0309471.ref019","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1038\/s41379-019-0287-8","article-title":"Histone H3K27 dimethyl loss is highly specific for malignant peripheral nerve sheath tumor and distinguishes true PRC2 loss from isolated H3K27 trimethyl loss","volume":"32","author":"DM Marchione","year":"2019","journal-title":"Mod Pathol"},{"key":"pone.0309471.ref020","doi-asserted-by":"crossref","first-page":"151735","DOI":"10.1016\/j.anndiagpath.2021.151735","article-title":"Loss of H3K27me3 occurs in a large subset of embryonal rhabdomyosarcomas: Immunohistochemical and molecular analysis of 25 cases","volume":"52","author":"T Tomassen","year":"2021","journal-title":"Ann Diagn Pathol"},{"issue":"3","key":"pone.0309471.ref021","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/his.14823","article-title":"Loss of H3K27 trimethylation in a distinct group of de-differentiated chordoma of the skull base","volume":"82","author":"N Makise","year":"2023","journal-title":"Histopathology"},{"issue":"1","key":"pone.0309471.ref022","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s40478-023-01514-z","article-title":"Common molecular features of H3K27M DMGs and PFA ependymomas map to hindbrain developmental pathways","volume":"11","author":"M Pun","year":"2023","journal-title":"Acta Neuropathol Commun"},{"issue":"3","key":"pone.0309471.ref023","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/s004390050630","article-title":"The human histone gene cluster at the D6S105 locus","volume":"101","author":"W Albig","year":"1997","journal-title":"Hum Genet"},{"key":"pone.0309471.ref024","doi-asserted-by":"crossref","first-page":"16878","DOI":"10.1038\/s41598-017-17204-5","article-title":"QuPath: Open source software for digital pathology image analysis","volume":"7","author":"P Bankhead","year":"2017","journal-title":"Sci Rep"},{"key":"pone.0309471.ref025","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1038\/modpathol.3800491","article-title":"TMA-Combiner, a simple software tool to permit analysis of replicate cores on tissue microarrays","volume":"18","author":"CL Liu","year":"2005","journal-title":"Mod Pathol"},{"issue":"5","key":"pone.0309471.ref026","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1046\/j.1365-2559.1999.00632.x","article-title":"Nuclear expression of p53, p21 and cyclin D1 is increased in bronchioloalveolar carcinoma","volume":"34","author":"JW McDonald","year":"1999","journal-title":"Histopathology"},{"issue":"6","key":"pone.0309471.ref027","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.neo.2019.03.012","article-title":"Global Reduction of H3K4me3 Improves Chemotherapeutic Efficacy for Pediatric Ependymomas","volume":"21","author":"R Lewis","year":"2019","journal-title":"Neoplasia"},{"key":"pone.0309471.ref028","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/1097-0142(19950101)75:1+<203::AID-CNCR2820751308>3.0.CO;2-V","article-title":"Bone cancers","volume":"75","author":"HD Dorfman","year":"1995","journal-title":"Cancer"},{"key":"pone.0309471.ref029","doi-asserted-by":"crossref","first-page":"e14406","DOI":"10.2196\/14406","article-title":"Quality of Life of Patients With Osteosarcoma in the European American Osteosarcoma Study-1 (EURAMOS-1): Development and Implementation of a Questionnaire Substudy","volume":"8","author":"G Calaminus","year":"2019","journal-title":"JMIR Res Protoc"},{"key":"pone.0309471.ref030","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13148-018-0605-x","article-title":"Elevated H3K27me3 levels sensitize osteosarcoma to cisplatin","volume":"11","author":"C He","year":"2019","journal-title":"Clin Epigenet"},{"issue":"2","key":"pone.0309471.ref031","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00401-019-02025-9","article-title":"Lack of H3K27 trimethylation is associated with 1p\/19q codeletion in diffuse gliomas","volume":"138","author":"K Filipski","year":"2019","journal-title":"Acta Neuropathol"},{"issue":"5","key":"pone.0309471.ref032","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1007\/s00428-021-03134-1","article-title":"H3K27me3 immunostaining is diagnostic and prognostic in diffuse gliomas with oligodendroglial or mixed oligoastrocytic morphology","volume":"479","author":"S Ammendola","year":"2021","journal-title":"Virchows Arch"},{"issue":"1","key":"pone.0309471.ref033","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/his.13506","article-title":"Extraskeletal osteosarcoma: MDM2 and H3K27me3 analysis of 19 cases suggest disease heterogeneity","volume":"73","author":"N Makise","year":"2018","journal-title":"Histopathology"},{"key":"pone.0309471.ref034","doi-asserted-by":"crossref","first-page":"1009548","DOI":"10.3389\/fonc.2022.1009548","article-title":"Reversion of methionine addiction of osteosarcoma cells to methionine independence results in loss of malignancy, modulation of the epithelial-mesenchymal phenotype and alteration of histone-H3 lysine-methylation","volume":"12","author":"Y Aoki","year":"2022","journal-title":"Front Oncol"},{"issue":"1","key":"pone.0309471.ref035","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s13148-016-0255-9","article-title":"p38-MAPK\/MSK1-mediated overexpression of histone H3 serine 10 phosphorylation defines distance-dependent prognostic value of negative resection margin in gastric cancer","volume":"8","author":"SA Khan","year":"2016","journal-title":"Clin Epigenet"},{"issue":"2","key":"pone.0309471.ref036","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/s41389-020-0195-2","article-title":"STAT3 activates MSK1-mediated histone H3 phosphorylation to promote NFAT signaling in gastric carcinogenesis","volume":"9","author":"H Qi","year":"2020","journal-title":"Oncogenesis"},{"issue":"15","key":"pone.0309471.ref037","doi-asserted-by":"crossref","first-page":"19863","DOI":"10.18632\/oncotarget.7887","article-title":"Prognostic role of STAT3 in solid tumors: a systematic review and meta-analysis","volume":"7","author":"P Wu","year":"2016","journal-title":"Oncotarget"},{"issue":"15","key":"pone.0309471.ref038","doi-asserted-by":"crossref","first-page":"4426","DOI":"10.1093\/emboj\/17.15.4426","article-title":"Mitogen- and stress-activated protein kinase-1 (MSK1) is directly activated by MAPK and SAPK2\/p38, and may mediate activation of CREB","volume":"17","author":"M Deak","year":"1998","journal-title":"EMBO J"},{"issue":"12","key":"pone.0309471.ref039","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1002\/jor.25023","article-title":"MEK inhibition preferentially suppresses anchorage-independent growth in osteosarcoma cells and decreases tumors in vivo","volume":"39","author":"T Shimizu","year":"2021","journal-title":"J Orthop Res"},{"issue":"50","key":"pone.0309471.ref040","doi-asserted-by":"crossref","first-page":"E11681","DOI":"10.1073\/pnas.1811818115","article-title":"Coordinated histone modifications and chromatin reorganization in a single cell revealed by FRET biosensors","volume":"115","author":"Q Peng","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"pone.0309471.ref041","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/ncb1668","article-title":"Phosphorylation of histone H3 at threonine 11 establishes a novel chromatin mark for transcriptional regulation","volume":"10","author":"E Metzger","year":"2008","journal-title":"Nat Cell Biol"},{"issue":"4","key":"pone.0309471.ref042","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.ccell.2016.03.009","article-title":"Intratumoral Heterogeneity of the Epigenome","volume":"29","author":"T Mazor","year":"2016","journal-title":"Cancer Cell"},{"issue":"1","key":"pone.0309471.ref043","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1038\/s41467-021-23119-7","article-title":"Author Correction: Single-cell RNA landscape of intratumoral heterogeneity and immunosuppressive microenvironment in advanced osteosarcoma","volume":"12","author":"Y Zhou","year":"2021","journal-title":"Nat Commun"},{"issue":"1","key":"pone.0309471.ref044","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s12915-023-01593-3","article-title":"Osteosarcoma tumors maintain intra-tumoral transcriptional heterogeneity during bone and lung colonization","volume":"21","author":"S Rajan","year":"2023","journal-title":"BMC Biol"},{"issue":"2","key":"pone.0309471.ref045","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.cell.2006.02.041","article-title":"A bivalent chromatin structure marks key developmental genes in embryonic stem cells","volume":"125","author":"BE Bernstein","year":"2006","journal-title":"Cell"},{"issue":"1","key":"pone.0309471.ref046","doi-asserted-by":"crossref","first-page":"458","DOI":"10.18632\/oncotarget.13444","article-title":"Tumorigenicity of Ewing sarcoma is critically dependent on the trithorax proteins MLL1 and menin","volume":"8","author":"LK Svoboda","year":"2017","journal-title":"Oncotarget"},{"issue":"11","key":"pone.0309471.ref047","doi-asserted-by":"crossref","first-page":"9113","DOI":"10.18632\/oncotarget.3272","article-title":"Overexpression of mutant Ptch in rhabdomyosarcomas is associated with promoter hypomethylation and increased Gli1 and H3K4me3 occupancy","volume":"6","author":"F Nitzki","year":"2015","journal-title":"Oncotarget"},{"issue":"6424","key":"pone.0309471.ref048","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1126\/science.aau0583","article-title":"H3K9me3-heterochromatin loss at protein-coding genes enables developmental lineage specification","volume":"363","author":"D Nicetto","year":"2019","journal-title":"Science"},{"issue":"4","key":"pone.0309471.ref049","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s00109-023-02294-8","article-title":"Histone H3K9 methyltransferase SETDB1 overexpression correlates with pediatric high-grade gliomas progression and prognosis","volume":"101","author":"A Klonou","year":"2023","journal-title":"J Mol Med (Berl)"},{"issue":"3","key":"pone.0309471.ref050","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1007\/s13311-021-01090-x","article-title":"Histone Mark Profiling in Pediatric Astrocytomas Reveals Prognostic Significance of H3K9 Trimethylation and Histone Methyltransferase SUV39H1","volume":"18","author":"A Klonou","year":"2021","journal-title":"Neurotherapeutics"},{"key":"pone.0309471.ref051","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.molcel.2013.10.030","article-title":"Polycomb-Dependent H3K27me1 and H3K27me2 Regulate Active Transcription and Enhancer Fidelity","volume":"53","author":"K Ferrari","year":"2014","journal-title":"Mol cell"},{"key":"pone.0309471.ref052","doi-asserted-by":"crossref","first-page":"151967","DOI":"10.1016\/j.anndiagpath.2022.151967","article-title":"Loss of dimethylated H3K27 (H3K27me2) expression is not a specific marker of malignant peripheral nerve sheath tumor (MPNST): An immunohistochemical study of 137 cases, with emphasis on MPNST and melanocytic tumors","volume":"59","author":"JJ Thangaiah","year":"2022","journal-title":"Ann Diagn Pathol"},{"key":"pone.0309471.ref053","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00401-021-02382-4","article-title":"EZHIP: a new piece of the puzzle towards understanding pediatric posterior fossa ependymoma","volume":"143","author":"A Jenseit","year":"2022","journal-title":"Acta Neuropathol"},{"key":"pone.0309471.ref054","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/modpathol.2015.134","article-title":"Loss of H3K27 trimethylation distinguishes malignant peripheral nerve sheath tumors from histologic mimics","volume":"29","author":"I Schaefer","year":"2016","journal-title":"Mod Pathol"},{"key":"pone.0309471.ref055","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S1097-2765(03)00288-0","article-title":"Structural Basis for Histone and Phosphohistone Binding by the GCN5 Histone Acetyltransferase","volume":"12","author":"A Clements","year":"2003","journal-title":"Mol. Cell"},{"key":"pone.0309471.ref056","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1158\/1535-7163.MCT-11-0333","article-title":"The aurora kinase inhibitor CCT137690 downregulates MYCN and sensitizes MYCN-amplified neuroblastoma in vivo","volume":"10","author":"A Faisal","year":"2011","journal-title":"Mol Cancer Ther"},{"key":"pone.0309471.ref057","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s13148-020-00941-2","article-title":"Rebelled epigenome: histone H3S10 phosphorylation and H3S10 kinases in cancer biology and therapy","volume":"12","author":"D Komar","year":"2020","journal-title":"Clin Epigenet"},{"key":"pone.0309471.ref058","doi-asserted-by":"crossref","first-page":"109395","DOI":"10.1016\/j.biopha.2019.109395","article-title":"PCAF regulates H3 phosphorylation and promotes autophagy in osteosarcoma cells","volume":"118","author":"D Kong","year":"2019","journal-title":"Biomed. Pharmacother"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0309471","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T13:41:00Z","timestamp":1732196460000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0309471"}},"subtitle":[],"editor":[{"given":"Zhiming","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2024,11,21]]},"references-count":58,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2024,11,21]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0309471","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2023.09.13.23295510","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,21]]}}}